Program

42
1
1

Journal Year Published

14
5
16
4
1
1
1
1

Author

43
182
174
134
134
125
118
116
114
108
88
86
81
73
56
51
50
43
42
34

Category

25
23
20
4
2
1
1

Keyword

9
8
6
5
5
4
4
3
3
3
2
2
2
2
2
2
2
2
2
1

Journal

5
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1

NCATS Publications

Human-Mouse Chimeras with Normal Expression and Function Reveal That Major Domain Swapping Is Tolerated by P-Glycoprotein (ABCB1).


Pluchino KM, Hall M, Moen JK, Chufan EE, Fetsch PA, Shukla S, Gill DR, Hyde SC, Xia D, Ambudkar SV, Gottesman MM


Biochemistry , (55), 1010-23, 2016.

Article Pubmed

Sample image from publication page

PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells.


Ho WS, Feldman MJ, Maric D, Amable L, Hall M, Feldman GM, Ray-Chaudhury A, Lizak MJ, Vera JC, Robison RA, Zhuang Z, Heiss JD


Oncotarget , (7), 12447-63, 2016.

Article Pubmed

Sample image from publication page

CNS uptake of bortezomib is enhanced by P-glycoprotein inhibition: implications for spinal muscular atrophy.


Foran E, Kwon DY, Nofziger JH, Arnold ES, Hall M, Fischbeck KH, Burnett BG


Neurobiol. Dis. , (88), 118-24, 2016.

Article Pubmed

Sample image from publication page

Tariquidar Is an Inhibitor and Not a Substrate of Human and Mouse P-glycoprotein.


Weidner LD, Fung KL, Kannan P, Moen JK, Kumar JS, Mulder J, Innis RB, Gottesman MM, Hall M


Drug Metab. Dispos. , (44), 275-82, 2016.

Article Pubmed

Sample image from publication page

Toward a Better Understanding of the Complexity of Cancer Drug Resistance.


Gottesman MM, Lavi O, Hall M, Gillet JP


Annu. Rev. Pharmacol. Toxicol. , (56), 85-102, 2016.

Article Pubmed

Evaluation of fluorophore-tethered platinum complexes to monitor the fate of cisplatin analogs.


Jagodinsky JC, Sulima A, Cao Y, Poprawski JE, Blackman BN, Lloyd JR, Swenson RE, Gottesman MM, Hall M


J. Biol. Inorg. Chem. , (20), 1081-95, 2015.

Article Pubmed

Sample image from publication page

The Inhibitor Ko143 Is Not Specific for ABCG2.


Weidner LD, Zoghbi SS, Lu S, Shukla S, Ambudkar SV, Pike VW, Mulder J, Gottesman MM, Innis RB, Hall M


J. Pharmacol. Exp. Ther. , (354), 384-93, 2015.

Article Pubmed

Sample image from publication page

Reduced accumulation of platinum drugs is not observed in drug-resistant ovarian cancer cell lines derived from cisplatin-treated patients.


Stukova M, Hall M, Tsotsoros SD, Madigan JP, Farrell NP, Gottesman MM


J. Inorg. Biochem. , (149), 45-8, 2015.

Article Pubmed

Sample image from publication page

The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicity.


Chang KE, Wei BR, Madigan JP, Hall M, Simpson RM, Zhuang Z, Gottesman MM


Mol. Cancer Ther. , (14), 90-100, 2015.

Article Pubmed

Sample image from publication page

Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes.


Hall M, Telma KA, Chang KE, Lee TD, Madigan JP, Lloyd JR, Goldlust IS, Hoeschele JD, Gottesman MM


Cancer Res. , (74), 3913-22, 2014.

Article Pubmed

Sample image from publication page